IP Library Granted Patent US 8,173,401
Granted Patent B2
US 8,173,401 · App. 12/495,705 · Granted May 8, 2012

Method for direct amplification from crude nucleic acid samples

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,173,401
App. No.
12/495,705
Granted
May 8, 2012
Kind
B2
Abstract

The present teachings relate to improved methods, kits, and reaction mixtures for amplifying nucleic acids. In some embodiments a novel direct buffer formulation is provided which allows for the direct amplification of the nucleic acids in a crude sample with minimal sample purification.

Claims (24)

1. A method of performing a polymerase chain reaction (PCR) comprising:

providing a crude sample comprising deoxyribonucleic acid;

optionally incubating the crude sample with NaOH;

mixing the crude sample with a direct buffer to form a nucleic acid containing solution; and

performing a PCR on the nucleic acid containing solution, wherein the direct buffer comprises at least 0.2%-0.9% polysorbate, 3%-8% glycerol, and 1000-3000 ug/ml BSA, wherein said direct buffer comprises at least one primer pair.

2. The method according to claim 1 , wherein the direct buffer further comprises, 10-50 mM Tris-HCI (pH 8.3), 30-80 mM KCI, 1.4-2.4 mM MgCl 2 , 0.01%-0.04% Sodium azide, 100-350 uM of each dNTP, and 0.10-0.35 U/ul of DNA polymerase.

3. The method according to claim 1 , wherein the polysorbate is polysorbate 20.

4. A method of determining the identity of a human comprising:

providing a crude sample comprising deoxyribonucleic acid from the human;

optionally incubating the crude sample with NaOH;

mixing the crude sample with a direct buffer to form a nucleic acid containing solution, wherein the direct buffer comprises a plurality of primer pairs, wherein each primer pair flanks a genomic locus containing a short tandem repeat (STR);

performing a PCR on the nucleic acid containing solution to form a plurality of PCR amplicons, wherein each PCR amplicon has an ascertainable size; and

identifying the human by reference to the size of the PCR amplicons, wherein the direct buffer further comprises 0.2%-0.9% polysorbate, 3%-8% glycerol, and 1000-3000 ug/ml BSA.

5. The method according to claim 4 , wherein the direct buffer further comprises 10-50 mM Tris-HCI (pH 8.3), 30-80 mM KCI, 1.4-2.4 mM MgCl 2 , 0.01%-0.04% Sodium azide, 100-350 uM of each dNTP, and 0.10-0.35 U/ul of DNA polymerase.

6. The method according to claim 4 , wherein the polysorbate is polysorbate 20.

7. A method of preparing nucleic acids comprising:

providing a crude sample comprising deoxyribonucleic acid;

optionally incubating the crude sample with NaOH;

mixing the crude sample with a direct buffer to form a nucleic acid containing solution; and

performing a downstream enzymatic manipulation on the solution, wherein the direct buffer comprises 0.2%-0.9% polysorbate, 3%-8% glycerol, and 1000-3000 ug/ml BSA, wherein said direct buffer comprises at least one primer pair.

8. The method according to claim 7 , wherein the downstream enzymatic manipulation is a PCR.

9. The method according to claim 7 , wherein the direct buffer further comprises 10-50 mM Tris-HCI (pH 8.3), 30-80 mM KCI, 1.4-2.4 mM MgCl 2 , 0.01%-0.04% Sodium azide, 100-350 uM of each dNTP, and 0.10-0.35 U/ul of DNA polymerase.

10. The method according to claim 7 , wherein the direct buffer further comprises 10-50 mM Tris-HCI (pH 8.3), 30-80 mM KCI, 1.4-2.4 mM MgCl 2 , 0.01%-0.04% Sodium azide, 100-350 uM of each dNTP, 1200-3000 ug/ml BSA, and 0.10-0.35 U/ul of DNA polymerase.

11. The method according to claim 7 , wherein the polysorbate is polysorbate 20.